From: Registration of systematic reviews in PROSPERO: 30,000 records and counting
Characteristic | Frequency (%) |
---|---|
Focus of SR | |
 Therapeutic | 78 (52%) |
 Epidemiologic | 47 (31%) |
 Diagnostic | 7 (5%) |
 Prognostic | 4 (3%) |
 Other | 14 (9%) |
Health area addressed (ICD-10 chapter) | |
 Diseases of the circulatory system | 16 (11%) |
 Mental and behavioural disorders | 16 (11%) |
 Diseases of the musculoskeletal system and connective tissue | 15 (10%) |
 Factors influencing health status and contact with health services | 12 (8%) |
 Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified | 11 (7%) |
 Certain infectious and parasitic diseases | 10 (7%) |
 Neoplasms | 10 (7%) |
 Diseases of the digestive system | 9 (6%) |
 Diseases of the genitourinary system | 8 (5%) |
 Endocrine, nutritional and metabolic diseases | 8 (5%) |
 Diseases of the respiratory system | 7 (5%) |
 Diseases of the nervous system | 6 (4%) |
 Pregnancy, childbirth and the puerperium | 6 (4%) |
 Injury, poisoning and certain other consequences of external causes | 4 (3%) |
 Certain conditions originating in the perinatal period | 3 (2%) |
 Congenital malformations, deformations and chromosomal abnormalities | 3 (2%) |
 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | 3 (2%) |
 Diseases of the skin and subcutaneous tissue | 3 (2%) |
 Diseases of the eye and adnexa | 0 (0%) |
 Diseases of the ear and mastoid process | 0 (0%) |
 External causes of morbidity and mortality | 0 (0%) |
Country of corresponding author | |
 England | 27 (18%) |
 Australia | 21 (14%) |
 China | 17 (11%) |
 Brazil | 16 (11%) |
 USA | 16 (11%) |
 Canada | 12 (8%) |
 Other (fewer than 5 reviews per country, including Argentina, Bangladesh, Belgium, Denmark, Ethiopia, France, Germany, Greece, Hong Kong, Hungary, India, Iran, Ireland, Italy, Japan, New Zealand, Norway, Scotland, Spain, Sweden Switzerland, The Netherlands) | 41 (27%) |
Funding of SR | |
 Non-profit | 66 (44%) |
 For-profit | 0 (0%) |
 Authors specified there was no funding | 84 (56%) |